$0.16
-0.01 (-7.09%)
Open$0.18
Previous Close$0.18
Day High$0.18
Day Low$0.16
52W High$9.70
52W Low$4.94
Volume—
Avg Volume46.9K
Market Cap2.26M
P/E Ratio—
EPS$-2.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,062.5% upside
Current
$0.16
$0.16
Target
$3.54
$3.54
$2.21
$3.54 avg
$4.26
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 287.57M | 246.54M | 4.60M |
| Net Income | -56,336,631 | -43,469,622 | 612.3K |
| Profit Margin | -19.6% | -18.6% | 13.3% |
| EBITDA | -50,172,585 | -40,864,159 | 960.1K |
| Free Cash Flow | — | — | 405.9K |
| Rev Growth | +16.6% | +16.6% | +11.5% |
| Debt/Equity | 3.44 | 3.44 | 0.89 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |